SARS ‐ CoV ‐2 antibody levels and long COVID occurrence in blood donors
Transfusion · 2024-09 · 64 (9) · 1719-1731
DOI: 10.1111/trf.17952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 10.07.2024. Verfasst von Vivian I Avelino-Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant Research Institute, California, San Francisco, USA. Hauptthemen laut MEDLINE: Blood Donors, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Long COVID is a common condition lacking consensus definition; determinants remain incompletely understood. Characterizing immune profiles associated with long COVID could support the development of preventive and therapeutic strategies.
Methods
We used a survey to investigate blood donors' infection/vaccination history and acute/persistent symptoms following COVID‐19. The prevalence of long COVID was evaluated using self‐report and an adapted definition from the RECOVER study. We evaluated factors associated with long COVID, focusing on anti‐spike and anti‐nucleocapsid SARS‐CoV‐2 antibodies. Lastly, we investigated long COVID clinical subphenotypes using hierarchical clustering.
Results
Of 33,610 participants, 16,003 (48%) reported having had COVID‐19; 1853 (12%) had self‐reported long COVID, 685 (4%) met an adapted RECOVER definition, and 2050 (13%) met at least one definition. Higher anti‐nucleocapsid levels measured 12–24 weeks post‐infection were associated with higher risk of self‐reported and RECOVER long COVID. Higher anti‐spike IgG levels measured 12–24 weeks post‐infection were associated with lower risk of self‐reported long COVID. Higher total anti‐spike measured 24–48 weeks post‐infection was associated with lower risk of RECOVER long COVID. Cluster analysis identified four clinical subphenotypes; patterns included neurological and psychiatric for cluster 1; neurological and respiratory for cluster 2; multi‐systemic for cluster 3; and neurological for cluster 4.
Discussion
Long COVID prevalence in blood donors varies depending on the adopted definition. Anti‐SARS‐CoV‐2 antibodies were time‐dependently associated with long COVID; higher anti‐nucleocapsid levels were associated with higher risk; and higher anti‐spike levels were associated with lower risk of long COVID. Different underlying pathophysiologic mechanisms may be associated with distinct clinical subphenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vitalant Research Institute, California, San Francisco, USA.
- Department of Epidemiology and Biostatistics, University of California San Francisco, California, San Francisco, USA.
- Department of Laboratory Medicine, University of California San Francisco, California, San Francisco, USA.
- South African Centre for Epidemiological Modeling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
- Creative Testing Solutions, Tempe, Arizona, USA.
- Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
ORCID-Profile: Vivian I Avelino-Silva, Roberta Bruhn, Eduard Grebe, Bryan R Spencer, Brian Custer
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Avelino-Silva, V. I., Bruhn, R., Zurita, K. G., Deng, X., Yu, E. A., Grebe, E., Stone, M., Lanteri, M. C., Spencer, B. R., Busch, M. P., & Custer, B. (2024). SARS ‐ CoV ‐2 antibody levels and long COVID occurrence in blood donors. Transfusion, 64(9), 1719-1731. https://doi.org/10.1111/trf.17952
Vancouver
Avelino-Silva VI, Bruhn R, Zurita KG, Deng X, Yu EA, Grebe E, et al. SARS ‐ CoV ‐2 antibody levels and long COVID occurrence in blood donors. Transfusion. 2024;64(9):1719-1731. doi:10.1111/trf.17952
BibTeX
@article{AvelinoSilva2024,
author = {Avelino-Silva, Vivian I and Bruhn, Roberta and Zurita, Karla G and Deng, Xutao and Yu, Elaine A and Grebe, Eduard and Stone, Mars and Lanteri, Marion C and Spencer, Bryan R and Busch, Michael P and Custer, Brian},
title = {SARS ‐ CoV ‐2 antibody levels and long COVID occurrence in blood donors},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {9},
pages = {1719--1731},
doi = {10.1111/trf.17952}
}
EUVIMED